Article 29 Apr 2025 Contracting For Success: Key Legal Considerations When Segmenting Pharmacy Benefit Programs (Podcast) United States Healthcare
Article 20 Mar 2025 Pharmacy Benefit Segmentation: Emerging Models For Health Plans (Podcast) United States Healthcare
Article 06 Mar 2025 Trump Prioritizes Health Care Pricing Transparency In New Executive Order United States Healthcare
Article 03 Jan 2025 Medicare Drug Price Negotiation Program: Centers For Medicare & Medicaid Services Releases New Discounted Prices For 2026 Selected Drugs United States Healthcare
Article 03 Dec 2024 PBM Contracting And Administration: What Are The Rules Of The Road For Self-Insured Employees? United States Healthcare
Article 22 Nov 2024 PBM Contracting: What Plans Should Know About The Emerging Models For Pharmacy Program Service Delivery United States Healthcare
Article 30 Sep 2024 Finding Calm During The PBM Storm: What Health Plans Can Do As FTC Litigation Intensifies United States Healthcare
Article 24 Sep 2024 Understanding Pharmacy Benefit Managers: The PBM Landscape Explained (Podcast) United States Healthcare
Article 21 Aug 2024 Medicare Drug Price Negotiation Program: CMS Releases New Discounted Prices For 2026 Selected Drugs United States Healthcare
Article 23 Jul 2024 CMS Releases Final Part Two Guidance On The Medicare Prescription Payment Plan: What's Changed For Part D Plans? United States Healthcare
Article 18 Jun 2024 Contracting With PBMs: Critical High-Value Issues To Consider United States Healthcare
Article 31 May 2024 Manufacturers Are "Winning" In The 340B Drug Discount Dispute United States Healthcare
Article 18 May 2024 Recent Developments In Pharmacy-Related Legislation And Regulations United States Healthcare
Article 07 May 2024 Proposed State And Federal PBM Legislation: Is There Reason For Action Now? United States Healthcare
Article 03 Apr 2024 CMS Updates Guidance On The Medicare Prescription Payment Plan: What Part D Plans Should Be Doing Now United States Healthcare
Article 22 Feb 2024 Health Care AI And Drug Prices: Highlights From Two Senate Hearings United States Healthcare